Cereno Scientific AB (OSTO:CRNO B) 5-Year EBITDA Growth Rate : 2.20% (As of Sep. 2024)

View and export this data going back to 2016. Start your Free Trial

What is Cereno Scientific AB 5-Year EBITDA Growth Rate?

Cereno Scientific AB's EBITDA per Share for the three months ended in Sep. 2024 was kr-0.05.

During the past 3 years, the average EBITDA Per Share Growth Rate was 5.80% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was 2.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 9 years, the highest 3-Year average EBITDA Per Share Growth Rate of Cereno Scientific AB was 63.80% per year. The lowest was -96.70% per year. And the median was 19.40% per year.

Competitive Comparison of Cereno Scientific AB's 5-Year EBITDA Growth Rate

For the Drug Manufacturers - Specialty & Generic subindustry, Cereno Scientific AB's 5-Year EBITDA Growth Rate, along with its competitors' market caps and 5-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Cereno Scientific AB's 5-Year EBITDA Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Cereno Scientific AB's 5-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Cereno Scientific AB's 5-Year EBITDA Growth Rate falls into.

Cereno Scientific AB 5-Year EBITDA Growth Rate Calculation

This is the 5-year average growth rate of EBITDA per Share. The growth rate is calculated with least square regression.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

Cereno Scientific AB (OSTO:CRNO B) 5-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

5-Year EBITDA Growth Rate gives an overview of the company's growth in operating profitability and is an important factor used in calculating Peter Lynch Fair Value.

Cereno Scientific AB 5-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Cereno Scientific AB's 5-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Cereno Scientific AB Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Cereno Scientific AB (OSTO:CRNO B) » Definitions » 5-Year EBITDA Growth Rate

Comparable Companies

Traded in Other Exchanges

4A1:Germany

Address

BioVentureHub, Pepparedsleden 1, Molndal, SWE, 431 83

Website

https://www.cerenoscientific.se

Cereno Scientific AB is developing a pipeline of preventive therapeutics to treat cardiovascular and rare diseases by epigenetic modulation through histone deacetylase inhibition (HDACi). The company's lead program, CS1, is a phase two dual-acting antithrombotic drug aimed at venous thrombosis and stroke prevention for atrial fibrillation. Cereno Scientificalso evaluates the potential of epigenetic modulation for rare diseases related to pulmonary fibrosis, thrombosis, inflammation, and high blood pressure in the pulmonary circulation system.

Cereno Scientific AB Headlines

No Headlines